{"title":"一名使用正常起搏器的患者出现氟卡尼中毒。","authors":"Sneha Chebrolu, Jonathan Mayl, Prashant Bhave","doi":"10.19102/icrm.2024.15075","DOIUrl":null,"url":null,"abstract":"<p><p>Flecainide is a class Ic anti-arrhythmic that demonstrates use dependence, meaning the medication has an increased effect on the myocardium at high heart rates. Flecainide toxicity can be identified by wide QRS complexes on an electrocardiogram (ECG). We discuss a case of a 75-year-old patient with a pacemaker who presented with concern for flecainide toxicity. The patient had several risk factors known to increase the likelihood for toxicity, including structural heart disease and acute kidney injury. The initial ECG showed tachycardia with wide QRS complexes. The patient had a pacemaker set in a tracking mode (DDD) that resulted in rapid ventricular pacing with failure to mode switch. However, with modification to the VVI mode, the patient experienced tachycardia resolution with an improvement in QRS complexes. This case emphasizes the use dependence of flecainide and illustrates the utility of pacing mode in the management of flecainide toxicity in patients with pacemakers.</p>","PeriodicalId":36299,"journal":{"name":"Journal of Innovations in Cardiac Rhythm Management","volume":"15 7","pages":"5951-5954"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11238885/pdf/","citationCount":"0","resultStr":"{\"title\":\"Flecainide Toxicity in a Patient with a Functioning Pacemaker.\",\"authors\":\"Sneha Chebrolu, Jonathan Mayl, Prashant Bhave\",\"doi\":\"10.19102/icrm.2024.15075\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Flecainide is a class Ic anti-arrhythmic that demonstrates use dependence, meaning the medication has an increased effect on the myocardium at high heart rates. Flecainide toxicity can be identified by wide QRS complexes on an electrocardiogram (ECG). We discuss a case of a 75-year-old patient with a pacemaker who presented with concern for flecainide toxicity. The patient had several risk factors known to increase the likelihood for toxicity, including structural heart disease and acute kidney injury. The initial ECG showed tachycardia with wide QRS complexes. The patient had a pacemaker set in a tracking mode (DDD) that resulted in rapid ventricular pacing with failure to mode switch. However, with modification to the VVI mode, the patient experienced tachycardia resolution with an improvement in QRS complexes. This case emphasizes the use dependence of flecainide and illustrates the utility of pacing mode in the management of flecainide toxicity in patients with pacemakers.</p>\",\"PeriodicalId\":36299,\"journal\":{\"name\":\"Journal of Innovations in Cardiac Rhythm Management\",\"volume\":\"15 7\",\"pages\":\"5951-5954\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11238885/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Innovations in Cardiac Rhythm Management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.19102/icrm.2024.15075\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/7/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Innovations in Cardiac Rhythm Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19102/icrm.2024.15075","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
氟卡尼是一种 Ic 类抗心律失常药物,具有使用依赖性,这意味着在心率较高时,药物对心肌的作用会增加。心电图(ECG)上的宽QRS波群可识别弗莱凯尼中毒。我们讨论了一例 75 岁的患者,患者装有心脏起搏器,因担心弗来卡尼中毒而就诊。该患者有几种已知会增加中毒可能性的危险因素,包括结构性心脏病和急性肾损伤。最初的心电图显示心动过速,QRS 波群较宽。患者的起搏器设置为跟踪模式(DDD),导致心室快速起搏,无法进行模式切换。然而,在改为 VVI 模式后,患者的心动过速得到缓解,QRS 波群也有所改善。该病例强调了对非卡尼的使用依赖性,并说明了起搏模式在治疗带起搏器患者的非卡尼毒性方面的作用。
Flecainide Toxicity in a Patient with a Functioning Pacemaker.
Flecainide is a class Ic anti-arrhythmic that demonstrates use dependence, meaning the medication has an increased effect on the myocardium at high heart rates. Flecainide toxicity can be identified by wide QRS complexes on an electrocardiogram (ECG). We discuss a case of a 75-year-old patient with a pacemaker who presented with concern for flecainide toxicity. The patient had several risk factors known to increase the likelihood for toxicity, including structural heart disease and acute kidney injury. The initial ECG showed tachycardia with wide QRS complexes. The patient had a pacemaker set in a tracking mode (DDD) that resulted in rapid ventricular pacing with failure to mode switch. However, with modification to the VVI mode, the patient experienced tachycardia resolution with an improvement in QRS complexes. This case emphasizes the use dependence of flecainide and illustrates the utility of pacing mode in the management of flecainide toxicity in patients with pacemakers.